NEW YORK >> Packaged food makers and fast-food restaurants may ‌be forced to overhaul more of their products next year as ...

Packaged food manufacturers and fast-food restaurants are preparing for major shifts in consumer demand as ...

Media reports say that the U.S. Food and Drug Administration (FDA) is being pushed internally to fast-track approval of Eli Lilly’s (LLY) experimental weight-loss pill called Orforglipron. Unlock ...

Appetite-suppressing GLP-1 tablets become accessible in January, and manufacturers and fast-food eateries may be pushed to alter more of their goods.

Novo Nordisk shares rose 7.5% in early trading on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge in the fast-evolving ...

Millions of Americans have successfully lost weight with semaglutides, the game-changing class of drugs that includes Ozempic, Mounjaro, and Wegovy. Still, many others are holding out for GLP-1 ...

Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying ...

Packaged food manufacturers and fast-food chains may be forced to revamp more of their offerings next year as newly approved ...

The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say ...

FILE PHOTO: Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly’s international president Patrik Jonsson said on ...

The market for weight-loss drug is expected to expand to more than $150 billion in revenue by the early 2030s, thanks to the ...

Weight Loss Medications Available Online If you’re eligible for weight loss medication, there are a fair number of options.